KatharinaEElliottMD

Pediatric Hematology & Oncology • Kalamazoo, MI

Medical Director, Pediatric Hematology/Oncology, Bronson methodist Hospital

Join to view full profile

Dr. Elliott is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Elliott's full profile

Already have an account?

Office
601 John St
Ste M-005
Kalamazoo, MI 49007
Phone+1 269-341-6350

Fax+1 269-341-8580
Is this information wrong?

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Hematology/Oncology, 1995 - 1998
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 1992 - 1995
New York Medical CollegeClass of 1992

Certifications & Licensure

CA State Medical License 1994 - Present
MI State Medical License 1998 - 2026
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 Mar 26
Active, not recruiting
Phase 3
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Start of enrollment: 2004 Feb 16
Completed
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Start of enrollment: 2011 Apr 04
Completed
Phase 3
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Jun 20
Active, not recruiting
Phase 3
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
Join now to see all

Professional Memberships

American Society of Pediatric Hematology/Oncology
Member
American Society of Clinical Oncology - ASCO
Member
Children's Oncology Group
Member

Hospital Affiliations

Bronson Methodist HospitalKalamazoo, Michigan